XML 33 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2012
Stockholders' Equity [Abstract]  
Methodology for Determining Obligated Amount
With respect to each draw down, Kingsbridge is obligated to purchase (Obligated Amount) the amount determined under one of two methodologies that we choose at our discretion, subject to a maximum of the lesser of 3.5% of the closing market value of the outstanding shares of our common stock at the time of the draw down or $15 million.  The methodologies for determining the Obligated Amount are:
 
Methodology 1 – based on Threshold Price
 
Obligated
Amount
 
Threshold Price is:
   
Greater than $90.00 per share
 $7,250,000 
Greater than or equal to $75.00 but less than $90.00 per share
 $6,500,000 
Greater than or equal to $60.00 but less than $75.00 per share
 $4,250,000 
Greater than or equal to $45.00 but less than $60.00 per share
 $3,500,000 
Greater than or equal to $30.00 but less than $45.00 per share
 $2,750,000 
Greater than or equal to $18.75 but less than $30.00 per share
 $2,000,000 
Greater than or equal to $11.25 but less than $18.75 per share
 $1,350,000 
Greater than or equal to $7.50 but less than $11.25 per share
 $1,000,000 
Greater than or equal to $3.75 but less than $7.50 per share
 $500,000 
Greater than or equal to $3.00 but less than $3.75 per share
 $350,000 

Methodology 2
Under this method, the Obligated Amount is equal to: 8 (the trading days in the draw down period) multiplied by the adjusted average trading volume of our common stock (calculated as the average daily trading volume of the prior 40 trading days excluding the 5 trading days with the highest trading volume and the 5 trading days with the lowest trading volume) multiplied by the Threshold Price multiplied by 0.1985.
Purchase Price Discount of Shares Sold under 2010 CEFF
The purchase price of shares sold to Kingsbridge under the 2010 CEFF is at a discount to the VWAP (as defined in the agreement) for each of the trading days in the draw down period as follows:
 
Daily VWAP
 
% of VWAP
  
Applicable Discount
 
Greater than $6.00 per share
  95.62%  4.38%
Greater than or equal to $5.00 but less than $6.00 per share
  95.25%  4.75%
Greater than or equal to $4.00 but less than $5.00 per share
  94.75%  5.25%
Greater than or equal to $3.00 but less than $4.00 per share
  94.25%  5.75%
Greater than or equal to $2.00 but less than $3.00 per share
  94.00%  6.00%
Greater than or equal to $1.25 but less than $2.00 per share
  92.50%  7.50%
Greater than or equal to $0.75 but less than $1.25 per share
  91.50%  8.50%
Greater than or equal to $0.50 but less than $0.75 per share
  90.50%  9.50%
Greater than or equal to $0.25 but less than $0.50 per share
  85.00%  15.00%
Greater than or equal to $0.20 but less than $0.25 per share
  82.50%  17.50%
Common Stock Issued under 2010 CEFF
Financings that we completed under the 2010 CEFF are as follows:

(in thousands, except per share data)
     Discounted  
Completion Date
 
Shares Issued
  
Gross Proceeds
  
Average Price
Per Share
 
           
October 4, 2010
  351  $973  $2.77 
November 4, 2010
  166   432   2.60 
January 24, 2011
  314   991   3.16 
October 10, 2011
  35   69   1.97 
October 24, 2011
  37   63   1.71 
November 8, 2011
  129   218   1.69 
    1,032  $2,746     
Common Shares Reserved for Future Issuance, Warrants
The chart below summarizes shares of our common stock reserved for future issuance upon the exercise of warrants:
 
(in thousands, except  price per share data)
 
December 31,
  
Exercise
 Expiration
  
2012
  
2011
  
Price
 
Date
              
Former Employee Warrant
  30   30  $3.20 
3/18/2016
Investor Warrants – February 2011 Financing
  4,949   5,000  $2.80 
2/22/2016
Investor Warrants – February 2011 Financing
  -   5,000  $2.94 
5/22/2012
PharmaBio – October  2010 Financing
  79   79  $4.10 
10/13/2015
Investor Warrants – June 2010 Financing
  1,190   1,190  $6.00 
6/22/2015
Kingsbridge – June 2010 CEFF
  83   83  $6.69 
12/11/2015
PharmaBio – April 2010 Financing
  135   135  $10.59 
4/30/2015
Investor Warrants – February 2010 Financing
  917   917  $12.75 
2/23/2015
Investor Warrants – May 2009 Financing
  467   467  $17.25 
5/13/2014
Kingsbridge – December 2008 CEFF
  45   45  $22.70 
6/12/2014
Kingsbridge – May 2008 CEFF
  55   55  $37.59 
11/22/2013
Total
  7,950   13,001      
Common Shares Reserved for Future Issuance, Share-Based Compensation
Stock options and awards outstanding and available for future issuance as of December 31, 2012 and 2011 are as follows:

  
As of December 31,
   
2012
  
2011
 
        
2011 Plan(1)
      
Outstanding
  3,365   1,709 
Available for Future Grants
  2,966   2,106 
Total
  6,331   3,815 
          
2007 Plan
        
Outstanding
  277   297 
Available for Future Grants
      
Total
  277   297 
          
1998 Plan
        
Outstanding
  355   432 
Available for Future Grants
      
Total
  355   432 
          
Total Outstanding
  3,997   2,438 
Total Available for Future Grants
  2,966   2,106 
Total
  6,963   4,544 
 
(1)  See, Note 11 – Stock Options and Stock-based Employee Compensation – Long-Term Incentive Plans.